Mutation of a serine that forms a hydrogen bond to the iron-sulfur cluster of the Rieske iron-sulfur protein to a cysteine results in a respiratory-deficient yeast strain due to formation of iron-sulfur protein lacking the ironsulfur cluster. The Rieske apoprotein lacking the ironsulfur cluster is inserted into both monomers of the dimeric cytochrome bc 1 complex and processed to mature size, but the protein lacking iron-sulfur cluster is more susceptible to proteolysis. In addition, the protein environment of center P in one half of the dimer is affected by failure to insert the iron-sulfur cluster as indicated by the fact that only one molecule of myxothiazol can be bound to the cytochrome bc 1 dimer. Although the bc 1 complex lacking the Rieske iron-sulfur cluster cannot oxidize ubiquinol through center P, rates of reduction of cytochrome b by menaquinol through center N are normal. However, less cytochrome b is reduced through center N, and only one molecule of antimycin can be bound at center N in the bc 1 dimer lacking iron-sulfur cluster. These results indicate that failure to insert the [2Fe-2S] cluster impairs assembly of the Rieske protein into the bc 1 complex and that this interferes with proper assembly of both center P and center N in one half of the dimeric enzyme.
The Rieske iron-suflur protein is an essential subunit of mitochondrial cytochrome bc 1 complexes that is encoded by a nuclear gene, synthesized on cytoplasmic ribosomes, and then imported into the mitochondria and assembled into the cytochrome bc 1 complex in the inner mitochondrial membrane (1) . During import and assembly into the bc 1 complex a presequence is cleaved from the iron-sulfur protein precursor, and a [2Fe-2S] cluster is inserted into the protein. In Neurospora crassa and Saccharomyces cerevisiae the presequence is removed in two steps, whereas in mammals the presequence is cleaved in a single step and retained as a subunit in the bc 1 complex (2) . In Schizosaccharomcyes pombe processing of the iron-sulfur protein precursor also occurs in one step but can be converted to two step processing by changing a proline in the presequence to a serine (3) . The two step processing of the iron-sulfur protein precursor that occurs in S. cerevisiae is not essential for import and assembly of functionally active ironsulfur protein into the bc 1 complex because mutated forms of the iron-sulfur protein that are processed to mature size in a single step are properly assembled into the bc 1 complex and are functional (4) .
We previously investigated the relationship between assembly of the apoprotein into the bc 1 complex and insertion of the [2Fe-2S] cluster in S. cerevisiae. We showed that the apoprotein can be assembled into the bc 1 complex if the cluster is not inserted (5) , which suggests that the [2Fe-2S] cluster is added after the apoprotein is assembled into the bc 1 complex. We also showed that if processing of intermediate to mature size ironsulfur protein is blocked by mutations in the presequence, the intermediate size iron-sulfur protein accumulates in the bc 1 complex and is functionally active (6) . This result establishes that the second protease-processing step takes place after intermediate size iron-sulfur protein has been assembled into the bc 1 complex and that the [2Fe-2S] cluster is inserted into the apoprotein before the second protease-processing step, although it does not establish that this sequence of events is obligatory.
We have now characterized the cytochrome bc 1 complex from a yeast mutant in which the [2Fe-2S] cluster is not inserted into the Rieske iron-sulfur protein due to a mutation of a serine that forms a hydrogen bond to the iron-sulfur cluster to a cysteine. We show that although the protein lacking the ironsulfur cluster is assembled into the bc 1 complex and processed to mature size, it is structurally abnormal, as evidenced by susceptibility to protease degradation. In addition, failure to insert the [2Fe-2S] cluster impairs both center P and center N. These results are discussed in relation to how insertion of the iron-sulfur cluster affects assembly of the Rieske protein into the bc 1 complex and the structure of the bc 1 dimer.
EXPERIMENTAL PROCEDURES
Materials-Dodecylmaltoside was obtained from Roche Molecular Biochemicals. DEAE-Biogel and ammonium persulfate were obtained from Bio-Rad Laboratories. Acrylamide and bis-acrylamide were from National Diagnostics. TEMED 1 was from Invitrogen. Yeast extract and peptone were from Difco. Nitrogen Base without amino acids but with ammonium sulfate was from US Biological. Antimycin, DFP, phenylmethylsulfonyl fluoride, menaquinone, and dithionite were purchased from Sigma. Stigmatellin was purchased from Fluka Biochemica.
Purification of bc 1 Complexes-Yeast cytochrome bc 1 complexes were isolated as described previously (7, 8) . The CHS14 yeast mutant was obtained by site-directed mutagenesis as described by Denke et al. (9) . The wild-type yeast strain, W303-1A, was grown in 1% yeast extract, 2% peptone, and 2% dextrose medium and harvested by centrifugation. The CHS14 yeast mutant was grown in a defined medium containing 2% dextrose, 0.7% of nitrogen base without amino acids but with ammonium sulfate, and 0.15% of amino acid supplement minus tryptophan.
Circular Dichroism Spectra of Purified Cytochrome bc 1 Complexes-
The bc 1 complexes were concentrated by ultracentrifugation as isolated at pH 7.0. Mediators were added to facilitate redox equilibration, and potentiometric titrations were monitored by CD spectroscopy using an OTTLE cell as described previously (9, 10) . The concentrations of the bc 1 complexes and the path-length of the OTTLE cell were 845 M and 40 m, respectively, for the enzyme from the wild-type yeast, and 430 M and 100 m for the enzyme from the CHS14 mutant. CD spectra were recorded at 4°C and a scan rate of 200 nm/min, accumulating four scans per spectrum. The fully reduced spectra were taken at Ϫ413 mV (wild-type) and Ϫ411 mV (CHS14), and the fully oxidized spectra were taken at ϩ487 mV (wild-type) and ϩ489 mV (CHS14). The spectra were taken after complete equilibration to the applied potentials, which are given relative to NHE.
Western Analysis of Mitochondrial Membranes and bc 1 ComplexesMitochondrial membranes and purified bc 1 complexes from W303 and CHS14 cells were resolved in 15% SDS-PAGE gels (11) . The gels were stained with Coomassie Blue or blotted to nitrocellulose membranes. Iron-sulfur protein and cytochrome c 1 were detected by Western blotting (12) using monoclonal antibodies to the yeast proteins (5) . The stained gels were scanned, and the intensities of the signal were quantified using a UMAX scanner and the NIH Image software.
Determination of Inhibitor Concentrations-Each of the inhibitors was diluted in ethanol, and the concentration was determined from optical spectra obtained in an Aminco DW2a TM UV/Visible spectrophotometer with the OLIS DW2 conversion and OLIS software. The difference spectrum, after subtracting the ethanol background, was recorded from 250 -400 nm. To accurately determine the concentration for each inhibitor, the absorbance was measured at concentrations that yielded 0.1-0.15 absorbance units after diluting stock solutions of the inhibitors. To minimize random dilution errors, each dilution was performed 5 or 6 times, and the diluted solutions were combined. The extinction coefficients used to calculate the concentrations of the stock solutions were, for antimycin, 4.8 mM Ϫ1 cm Ϫ1 at 320 nm, for stigmatellin, 65.5 mM Ϫ1 cm Ϫ1 at 267 nm, and for myxothiazol, 10.5 mM Ϫ1 cm Ϫ1 at 313 nm (13) . All of the inhibitor dilutions were prepared daily, and the concentrations were determined before a titration was started.
Pre-steady State Reduction of Cytochrome b-Pre-steady state reduction of cytochrome b was followed at room temperature by stopped flow rapid scanning spectroscopy using the OLIS Rapid Scanning Monochromator (On-Line Instrument Systems, Inc., Bogart, GA). The spectrophotometer was equipped with a 1200 lines/nm grating blazed at 500 nm. This produced a 75-nm spectrum, centered at 550 nm, with a resolution of 0.4 nm. The dead time of the instrument was 2 ms, and the end of this period was chosen as time zero. Data was collected at 1000 scans/s. The rationale for this pre-steady state kinetics method was discussed previously (14) .
Reactions were started by rapid mixing of 3 M bc 1 complex in assay buffer containing 50 mM potassium phosphate, pH 6.0, 250 mM sucrose, 1 mM sodium azide, 0.2 mM EDTA, and 0.01% Tween 20 against an equal volume of the same buffer containing 50 M menaquinol. A fresh solution of menaquinol substrate was prepared from menaquinone before each experiment as described previously (8) . The bc 1 complex was diluted shortly before each titration. The exact bc 1 concentration was determined by difference spectra recorded in the Aminco DW2a TM spectrophotometer. The cytochrome c 1 concentration was determined from the difference spectrum of the ascorbate-reduced versus ferricyanideoxidized enzyme, using an extinction coefficient of 17.5 mM Ϫ1 cm Ϫ1 at 553-548 nm (15) . Cytochrome b concentration was determined from the difference spectrum of the dithionite-reduced versus ferricyanide-oxidized enzyme, using an extinction coefficient of 25 mM Ϫ1 cm Ϫ1 at 563-578 nm (15) . To determine the rate constants for reduction of cytochrome b through center N, the bc 1 complex from the wild-type yeast was mixed with a 2-fold excess of stigmatellin to block the reaction through center P. It was not necessary to include stigmatellin with the bc 1 complex from the CHS14 mutant because the absence of iron-sulfur cluster prevents reduction of cytochrome b through center P.
To determine the titer for inhibition of the reduction of cytochrome b with antimycin, the antimycin was incubated with the enzyme 2 min before starting the reaction. An oxidized spectrum was obtained by mixing the oxidized bc 1 complex against assay buffer and averaging the data sets to a single scan. For each inhibitor concentration, three data sets were averaged, and the oxidized spectrum was subtracted from each scan. From the three-dimensional data set comprised of wavelength, absorbance, and time, the time course and amplitude change for cytochrome b reduction at 563 nm was extracted using the OLIS software.
Measurement of the Red Shift in the Cytochrome b Spectrum-The bc 1 complex was diluted to an approximate concentration of 3 M in assay buffer (pH 7.0), and the exact concentration was determined as described above. A baseline was obtained by reducing the bc 1 complex with dithionite in both sample and reference cuvettes in the Aminco DW2a TM spectrophotometer. Increasing amounts of antimycin were added to the sample cuvette and an equal amount of ethanol to the reference cuvette. After allowing the inhibitor to equilibrate with the enzyme for 2 min, a difference spectrum was recorded for each concentration of inhibitor added. For each inhibitor concentration the absorbance difference at 565-558 nm was determined. The same procedure was used to measure the red shift induced by myxothiazol binding, except the absorbance difference at 564 -559 nm was determined.
Quenching of Antimycin Fluorescence by the bc 1 Complex-Binding of antimycin to the wild-type and CHS14 mutant bc 1 complexes was measured by the quenching of antimycin fluorescence. The method was essentially as described by Berden and Slater (16) . Briefly, a sample of W303 or CHS14 bc 1 complex was diluted to an approximate concentration of 2 M in assay buffer at pH 7.0, and the exact concentration was determined in the Aminco DW2a TM spectrophotometer as described above. Antimycin fluorescence was measured with a Hitachi fluorescence spectrophotometer model F-3010 equipped with a 150 W xenon lamp using an excitation wavelength of 332 nm and an emission wavelength of 454 nm. Quartz cells of 10 nm light path for excitation and 5 nm light path for emission were used. The time average was set at 10 s for each reading, and the machine response was 2 s. Increasing amounts of antimycin were added to the bc 1 complex and incubated at room temperature for 2 min before measurement. Fluorescence by increasing amounts of antimycin in the absence of bc 1 complex was measured as a control for each titration. 1 Dimer-The yeast bc 1 complex was recently crystallized, and its three-dimensional structure has been determined (17) . The crystal structure showed that the yeast bc 1 complex is a dimer, as was previously shown for the beef and the chicken enzymes (18 -20) . In the dimer the two copies of the Rieske iron-sulfur protein are intertwined and oriented in a trans manner with respect to each monomer as shown in Fig. 1A . The head domain of the iron-sulfur protein comes in close contact with heme b L of cytochrome b and cytochrome c 1 of one monomer, whereas the N-terminal and transmembrane domains of the protein are anchored in the other monomer, close to heme b H. Confirmation of an intertwined dimer in solution was provided when a stable bc 1 complex from Rhodobacter sphaeroides was generated carrying two intersubunit disulfide bonds, one between the head domain of the iron-sulfur protein and cytochrome b and the other between the tail domain of the ironsulfur protein and cytochrome b (21) .
RESULTS

The Iron-Sulfur Protein Is Oriented in a trans Manner in the bc
The iron-sulfur protein molecule contains three domains, an extrinsic domain consisting of residues 93-215, a linker region consisting of residues 81-92, and a transmembrane domain consisting of residues 51-80. The extrinsic domain carries the iron-sulfur cluster and forms, together with a domain in cytochrome b proximal to heme b L , the ubiquinol oxidizing pocket, center P (17, 20, 22) . The transmembrane region of the ironsulfur protein is an alpha helix, as shown in Fig. 1A . The tail of the transmembrane region comes within 20 Å of the quinone reducing center N. This is the region where ubiquinone closely interacts with heme b H of cytochrome b, indicated by the arrow pointing to the ubiquinone head-group in Fig. 1A . The transmembrane domain of the iron-sulfur protein is in close contact with helix E of cytochrome b, which abuts heme b H at center N.
Three layers of antiparallel ␤-strands surround the [2Fe-2S] cluster, which is coordinated by His-161, His-181, Cys-159, and Cys-178 as shown in Fig. 1B . A hydrogen bond network to the iron-sulfur cluster includes Ser-183 and Tyr-185, located in the ␤7 strand. These two residues are conserved in all Rieske iron-sulfur proteins that oxidize ubiquinol. The hydroxyl group of Ser-183 is hydrogen-bonded to S1 at a distance of 3.2 Å.
In a previous study (9) we characterized mutations in Ser-183 that altered the cytochrome c reductase activity of the bc 1 complex due to changes in the midpoint potential of the ironsulfur protein. An S183T mutation that weakened the hydrogen bond from Ser-183 to the iron-sulfur cluster dropped the midpoint potential by 26 mV and caused a 20% loss of activity. An S183A mutation that eliminated the hydrogen bond dropped the midpoint potential of the iron-sulfur protein from ϩ285 mV to ϩ150 mV and caused a 90% loss of activity. We also noted that when Ser-183 was replaced with Cys the resulting yeast were petite and the mitochondrial membranes had no bc 1 complex activity (6, 9) . However, we did not investigate the basis for loss of bc 1 complex activity. We thus proceeded to further characterize the bc 1 complex from the respiratory-deficient yeast carrying the S183C mutation in the Rieske iron-sulfur protein.
Insertion of Iron-Sulfur Protein Lacking the Iron-Sulfur Cluster into the Cytochrome bc 1 Complex-We first examined the iron-sulfur cluster in the isolated bc 1 complex from the CHS14 yeast mutant carrying the S183C mutation in the Rieske protein and compared it with that from a wild-type bc 1 complex. In the reduced state the bc 1 complex from wild-type yeast shows a negative CD band at 500 nm, which is free of interfering signals as shown in Fig. 2A . The bc 1 complex from the CHS14 mutant lacks the 500 nm band (Fig. 2B) , indicating that the cluster is absent and therefore explaining the absence of bc 1 complex activity in the mutant (6, 9) . Because the 500-nm CD band characteristic of the iron-sulfur cluster was not detectable, no attempt was made to characterize the cluster by EPR spectroscopy.
We previously observed that mutations in the highly conserved cysteines and histidines that ligate the cluster cause loss of the iron-sulfur cluster and very low amounts of the apoprotein present in the bc 1 complexes from those mutants 
FIG. 2.
Circular dichroism spectra of purified cytochrome bc 1 complexes from wild-type yeast and the CHS14 mutant. The fully reduced spectra were taken at Ϫ413 mV (wild-type) and Ϫ411 mV (CHS14), and the fully oxidized spectra were taken at ϩ487 mV (wild-type) and ϩ489 mV (CHS14).
(5). To check for loss of the iron-sulfur apoprotein from the bc 1 complex in the CHS14 mutant, we performed a Western blot analysis to compare the amounts of apoprotein in mitochondrial membranes and isolated enzyme. The top panel in Fig. 3 shows the Western blot analysis of wild-type and CHS14 membranes and pure bc 1 complexes, and the lower panel shows the quantification of the scans. The amount of cytochrome c 1 in each sample was arbitrarily set at 100%, and the amount of iron-sulfur protein relative to cytochrome c 1 was calculated from the densitometry scan. The amount of iron-sulfur protein relative to cytochrome c 1 in the purified bc 1 complex from the CHS14 mutant is 83% of that in the wild-type bc 1 complex, if the enzyme is isolated in the presence of the protease inhibitor DFP (Fig. 3) . This indicates that the apoprotein is assembled into both halves of the bc 1 dimer but somewhat more readily lost from the enzyme if the iron-sulfur cluster is absent. Lack of iron-sulfur cluster does not affect processing of the protein to mature size by the mitochondrial processing peptidases because there is no accumulation of intermediate-ISP in the membranes or in the isolated enzyme from the CHS14 mutant.
This contrasts with mutants where amino acids in the presequence that are recognized by mitochondrial processing peptidases have been mutated (11) .
Although the iron-sulfur protein is assembled into the bc 1 complex and processed to mature size in the CHS14 mutant, it is more sensitive to proteolysis than the iron-sulfur protein in the membranes from the wild-type yeast if protease inhibitor is omitted. When membranes were isolated from the wild-type yeast without DFP there is a small, but detectable, amount of proteolysis of the iron-sulfur protein in the membranes (Fig. 3) . Consequently, the amounts of iron-sulfur protein relative to cytochrome c 1 in membranes isolated from the wild-type yeast in the presence or absence of DFP are essentially identical (ϩ5%).
If DFP is omitted during isolation of mitochondrial membranes from the CHS14 mutant, there is extensive proteolysis of the iron-sulfur protein as shown by the appearance of proteolytic degradation products as lower molecular weight bands. Consequently, the amount of iron-sulfur protein in membranes from the CHS14 mutant is only 58% as much in the wild-type membranes. By a similar Western blot analysis we observed that the proteolytic degradation products were lost when the bc 1 complex was purified from these membranes (results not shown).
As mentioned above, the residue mutated in the CHS14 mutant, Ser-183, has been changed to Thr, Ala, and Cys (9). The first two mutations caused a change in the iron-sulfur protein redox potential, but the protein remained in normal amounts and retained the cluster. It seems that the Ser-183 hydroxyl group is not essential for the formation of the cluster, as evidenced by the presence of the cluster in the S183A form of the protein. Although the S183C mutation caused the loss of the cluster, the apoprotein is stable if protected from proteolysis. Therefore, it appears that an additional Cys residue interferes with insertion of the [2Fe-2S] cluster, but it can stabilize the extrinsic domain and therefore the protein, possibly by forming a disulfide bridge with Cys-159 or Cys-178 in this region (see Fig. 1B ). Modeling of the S183C mutation indicates that the sulfur of the introduced Cys-183 is 4.15 Å from the sulfur of Cys-159 and 3.16 Å from the sulfur of Cys-178.
Failure to Insert the Iron-Sulfur Cluster Blocks Ubiquinol Oxidation and Additionally Impairs Assembly of Center P in the S183C
Mutant-Lack of the 500-nm signal in the CD spectrum of the mutant bc 1 complex (Fig. 2) shows conclusively that the iron-sulfur cluster is lost, whereas the Western blots (Fig.  3) show that the apoprotein remains in the membranes and in the purified enzyme. We thus decided to further characterize center P and center N in the purified enzyme to understand what effects the S183C mutation has on the structure of the bc 1 complex.
As expected, there was no reduction of cytochrome b or cytochrome c 1 via center P due to the absence of the iron-sulfur cluster (results not shown). There is also a change in the structure of center P, as indicated by a change in binding of myxothiazol to the bc 1 complex from the CHS14 mutant. Myxothiazol was shown to bind at center P of the bovine bc 1 complex with a stoichiometry of one myxothiazol per bc 1 monomer and to cause a red shift in the optical spectrum of cytochrome b L (13, 23, 24) . A binding stoichiometry of one myxothiazol per bc 1 monomer was similarly demonstrated for the yeast bc 1 complex by titrating the myxothiazol-induced shift in the cytochrome b optical spectrum (25) .
We thus used the shift in the cytochrome b optical spectrum induced by myxothiazol binding to probe the structure of center P in the bc 1 complex from the CHS14 mutant. As can be seen in Fig. 4 , whereas a binding stoichiometry of one myxothiazol per FIG. 3 . Immunoblot analysis of iron-sulfur protein content in mitochondrial membranes and isolated bc 1 complexes from wild-type yeast and the CHS14 mutant. Mitochondrial membranes and purified cytochrome bc 1 complexes were isolated in the presence of DFP from yeast containing wild-type (WT) and mutant iron-sulfur protein (CHS14). To determine the protease susceptibility of the samples the membranes were diluted into SDS gel buffer in the absence or presence of DFP as indicated, resolved by SDS-PAGE, and analyzed by Western blot analysis as shown at the top of the figure, using monoclonal antibodies to the Rieske iron-sulfur protein and cytochrome c 1 . The purified bc 1 complex was treated in the same manner, but no difference was observed (results not shown). The relative amounts of iron-sulfur protein and cytochrome c 1 , shown at the bottom of the figure, were determined by scanning the stained gel. The amount of cytochrome c 1 in each sample, indicated by the open bars, was arbitrarily set at 100%, and the amount of mature size iron-sulfur protein relative to cytochrome c 1 was calculated from the densitometry scan for the wildtype and mutant bc 1 complexes and for the wild-type membranes. bc 1 monomer was observed with the enzyme from the wild-type yeast, the stoichiometry with the enzyme from the CHS14 mutant was only 0.5 per bc 1 monomer. This result was unexpected because it has been shown that binding of similar methoxyacrylates is unaffected when the Rieske protein is extracted from the bovine bc 1 complex (22) . This suggests that failure to insert the iron-sulfur cluster alters the structure of center P.
Improper Assembly of the Rieske Iron-Sulfur Protein Interferes with Assembly of Center N in the S183C Mutant-To see if the S183C mutation had an effect on center N of the bc 1 complex, we examined the rates of cytochrome b reduction through center N in the CHS14 bc 1 complex as a function of menaquinol concentration. As can be seen in Fig. 5 , the second order rate constant for cytochrome b reduction in the wild-type bc 1 . From these results we conclude that the rate of electron transfer through center N is not significantly changed by the absence of iron-sulfur cluster. Although the rate constant is slightly smaller at higher menaquinol concentrations in the bc 1 complex from the CHS14 mutant than in the wild-type enzyme, we consider this change insignificant in view of the limited number of data points.
Although the rate of cytochrome b reduction is the same in the bc 1 complexes from the wild-type and CHS14 mutant, the amount of cytochrome b that is reducible through center N is significantly decreased in the mutant. Fig. 6 shows spectra of the bc 1 complexes after reduction with 25 M menaquinol and dithionite. Stigmatellin was included with the wild-type bc 1 complex to prevent reduction through center P in that enzyme. In the bc 1 complex from the wild-type yeast menaquinol reduced 59% of the dithionite-reducible cytochrome b. In contrast, menaquinol reduced only 37% of the dithionite-reducible cytochrome b in the CHS14 bc 1 complex. This difference remained constant when using higher concentrations of menaquinol. For example, 61 and 41% of the dithionite-reducible cytochrome b were reduced with 75 M menaquinol in the wild-type and mutant bc 1 complexes, respectively (data not shown). Notably, there is no damage to the cytochrome b in the CHS14 mutant bc 1 complex. The spectrum of the dithionitereduced bc 1 complex shows the same absorption maximum and the same 2:1 ratio of b:c 1 for the wild-type and mutant bc 1 complexes.
To further characterize center N in the mutant, we titrated the pre-steady state reduction of cytochrome b with antimycin as described previously (14, 25) . In this assay, bc 1 complex was pre-mixed with antimycin and then reduced with 25 M menaquinol. To block reduction of cytochrome b through center P in the wild-type bc 1 complex, the enzyme was mixed with stigmatellin. As shown in Fig. 7 , reduction of cytochrome b through center N is inhibited by antimycin. With bc 1 complex from wild-type yeast the stoichiometry is 1:1, but with the enzyme from the CHS14 mutant the stoichiometry is 0.5 antimycin per bc 1 monomer.
Antimycin causes a red shift in the alpha band of the cytochrome b spectrum upon binding to reduced bc 1 complex (13). Cytochrome bc 1 complexes from the wild-type (WT) yeast and the CHS14 mutant were reduced with 50 M menaquinol. A 2-fold excess of stigmatellin was added to the wild-type enzyme to prevent reduction through center P. The enzymes were then reduced with dithionite. The lower trace shows the menaquinol-reduced minus oxidized spectra, and the upper trace shows the dithionite-reduced minus oxidized spectra for both bc 1 complexes. Menaquinol reduced 59% of the dithionite-reduced cytochrome b in the wild-type bc 1 complex, whereas the mutant cytochrome b was reduced only 37% with menaquinol.
To further evaluate the titer for antimycin binding we titrated the antimycin-induced red shift in the spectrum of the CHS14 bc 1 complex and compared it the red shift of a wild-type bc 1 complex as shown in Fig. 8 . As antimycin is titrated into the wild-type bc 1 complex the absorbance change increases until a stoichiometry of one antimycin per bc 1 complex is obtained, after which there is very little absorbance change upon further additions of the inhibitor. In contrast, the titration of antimycin into the CHS14 bc 1 complex is biphasic. The absorbance increases incrementally until 0.5 equivalents of antimycin per bc 1 complex are added, and then there is a more gradual increment in absorbance as additional antimycin is added. These results indicate that antimycin binds with equal affinity to both center N sites in the dimeric bc 1 complex from the wild-type yeast but that it binds with significantly different affinities to the two sites in the bc 1 complex from the CHS14 mutant.
We also used the quenching of antimycin fluorescence to examine the binding stoichiometry. Upon binding to the bc 1 complex antimycin fluorescence is quenched, and when the enzyme becomes saturated further addition of antimycin results in incremental increases in fluorescence. This allows the binding to be measured under conditions where the b hemes are oxidized. As shown in Fig. 9 , quenching of the antimycin fluorescence is saturated in the wild-type bc 1 complex when the stoichiometry of binding reaches a value close to one equivalent of antimycin per bc 1 monomer, in agreement with the results previously obtained by this method (16) . The titer for quenching of antimycin fluorescence in the bc 1 complex from the CHS14 mutant indicated a high affinity binding site that becomes saturated at 0.5 equivalents per bc 1 complex, thus confirming the results from titration of the red shift in the optical spectrum. A second, lower affinity binding site is not obvious from the fluorescence quenching titration, but it is possible that it is not revealed in this titration due to the limited number of data points.
DISCUSSION
The striking finding from our results is that failure to insert the [2Fe-2S] cluster into the Rieske iron-sulfur affects the structure of center N, which is on the opposite side of the membrane from the extrinsic domain where the cluster is located. Although the head domain of the Rieske protein and center N are located on opposite sides of the mitochondrial membrane, there is genetic evidence for interaction between these two sites. In Rhodobacter capsulatus a series of revertants were isolated from mutations at Leu-136 of the Rhodobacter iron-sulfur protein, equivalent to Ile-167 in the yeast protein, which is located within 8.5 Å of the iron-sulfur cluster in the head domain of the Rieske protein (26) . Some of the revertants were compensatory mutations located on residues 44 or 46 of the N-terminal domain of the Rhodobacter protein, near center N. This indicates a structural interaction between the head domain of the Rieske protein and center N across the bacterial membrane. Single mutations generated on the latter two amino acids in the absence of the mutation on residue 136 were without phenotype as regards photosynthetic growth, inhibitor sensitivity, and EPR spectra, but the redox potential of the iron-sulfur cluster increased from 312 to 385 mV. This demonstrates that a structural change in the Nterminal domain of the Rieske protein can effect the properties of the iron-sulfur cluster.
By various criteria we found that 50% of the bc 1 complex was damaged at center P and center N. Because the bc 1 complex is a dimer this could indicate that 50% of the enzyme is damaged or that one monomer in all of the dimers is damaged. If the entire enzyme dimer were damaged, one would expect the extent of inactive enzyme to vary in multiple preparations. The fact that the titer for inhibitors was consistently diminished to one per dimer in multiple preparations of enzyme suggests that one monomer in all of the dimers is damaged.
The S183C mutation alters the binding of ligands at both centers P and N. The stoichiometry of myxothiazol binding in the bc 1 complex from the mutant indicates that center P can bind only one inhibitor per dimer. Whereas deletion of the gene for the Rieske iron-sulfur protein causes a decrease in the alpha band of cytochrome b (27) , the presence of a stable iron-sulfur protein without cluster does not have an effect on the spectrum of cytochrome b. This suggests that the structural change at center P is subtle and has not affected the heme b L environment.
The structural change at center N is also subtle. Although the decreased reduction of cytochrome b by menaquinol through center N suggests that menaquinol reacts with only one half of the dimer and only one antimycin is bound with high affinity to the dimer, the optical spectrum indicates there was no significant change in the heme b H environment.
The crystal structure of the bc 1 complex shows that the iron-sulfur protein forms center P of one monomer and is close to center N in the second monomer. Because the iron-sulfur protein is intertwined in the dimeric enzyme we hypothesize that a mutation in the extrinsic head domain of the iron-sulfur protein in one monomer exerts an effect across the membrane in a trans manner, affecting center N of the other monomer. The amounts of iron-sulfur protein in the purified enzyme from the CHS14 mutant indicate that the apoprotein is inserted into both halves of the dimer and remains during purification of the bc 1 complex. The extent of protease susceptibility of the protein lacking the iron-sulfur cluster suggests that the protein is not properly inserted into one of the monomers. Taken together these results suggest that the S183C mutation allows the correct insertion of one iron-sulfur protein, but not the second, and only the correctly inserted iron-sulfur protein allows binding of ligands in each center.
